共 45 条
- [34] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
- [37] A Spatial Gaussian-Process Boosting Analysis of Socioeconomic Disparities in Wait-Listing of End-Stage Kidney Disease Patients across the United States [J]. STATS, 2024, 7 (02): : 508 - 520
- [38] Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis [J]. JMIR MHEALTH AND UHEALTH, 2020, 8 (07):
- [40] Demographic trends and disparities in mortality related to coexisting heart failure and diabetes mellitus among older adults in the United States between 1999 and 2020: A retrospective population-based cohort study from the CDC WONDER database [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2024, 23